Smoking and Mental Health: The Real Relationship Between Cigarettes and Mood

People with mental health conditions smoke at dramatically higher rates than the general population. Adults with schizophrenia smoke at 3–4x the general population rate. People with depression or anxiety smoke at approximately 2x the rate of those without these conditions. This clustering is not coincidental — it reflects a complex bidirectional relationship.

The common belief is that people smoke to self-medicate mental health symptoms. The reality is more complicated: smoking both causes and is caused by psychiatric distress, through overlapping neurobiological mechanisms.

The Anxiety Paradox

Anxiety and smoking have one of the most clinically misleading relationships in psychiatry. The perceived wisdom: smoking relieves anxiety, therefore anxious people smoke more.

The reality: smoking causes anxiety, and also briefly relieves the anxiety it causes.

Here's the mechanism:

Nicotine normalizes an abnormal baseline — the baseline anxiety of a nicotine-dependent person includes the physiological discomfort of between-cigarette withdrawal
Smoking relieves this withdrawal-induced anxiety, which is experienced as anxiety relief
But over time, nicotine dysregulates the stress response system (HPA axis), making the smoker's baseline anxiety level higher than that of a non-smoker
The smoker needs cigarettes to return to their (now elevated) baseline — and never fully reaches the lower baseline of a non-smoker

Prospective studies confirm this: smoking precedes the development of anxiety disorders in many people — it's not purely self-medication of pre-existing anxiety. And longitudinal studies consistently find that long-term quitters have lower anxiety levels than when they were smoking.

Smoking and Depression

The smoking-depression relationship is similarly bidirectional:

Smoking causes depression: Nicotine dysregulates the dopaminergic and serotonergic systems that regulate mood. The dopamine deficit state that develops with dependence (low baseline dopamine between cigarettes) shares features with depressive states. Population studies show smokers have higher rates of current depression controlling for other factors.

Depression causes smoking: People with depression smoke at higher rates, partly due to impaired self-regulation (reduced executive control, which is a smoking vulnerability factor), partly due to nicotine's temporary antidepressant effect (genuine in the short term — nicotine increases dopamine and serotonin, producing a transient mood lift).

After quitting: Depression worsens temporarily during withdrawal in people with a history of depression, but long-term quitters with a history of depression have better mood outcomes than those who continue smoking. This is not intuitive but is consistent across studies.

Bupropion — both an antidepressant and a cessation medication — is the preferred pharmacological approach for smokers with comorbid depression.

Smoking and Psychosis/Schizophrenia

The extremely high smoking rates in schizophrenia (60–90% in some studies) represent a separate phenomenon. Several mechanisms have been proposed:

Self-medication hypothesis: Nicotine's cognitive effects — improved attention and working memory — may partially compensate for the attentional and cognitive deficits of schizophrenia. This appears to have some validity.

Antipsychotic side-effect reduction: Smoking reduces some side effects of first-generation antipsychotics (akathisia, muscle stiffness) by modulating dopaminergic signaling. This is a genuine pharmacological effect.

Shared genetic vulnerability: There is evidence of shared genetic factors predisposing to both nicotine dependence and psychotic disorder risk.

Drug interaction: Smoking induces CYP1A2 — the enzyme that metabolizes several antipsychotics including clozapine and olanzapine. This means smokers require higher doses of these medications. When a schizophrenic patient quits smoking, their antipsychotic blood levels can rise significantly — requiring medication adjustment.

Nicotine and ADHD

People with ADHD smoke at approximately 2x the rate of the general population. Nicotine's effects on the prefrontal cortex — improving dopaminergic signaling and attention — provide genuine, if temporary, symptom relief. This is particularly pronounced in undiagnosed or inadequately treated ADHD.

This has an important clinical implication: for people with ADHD who smoke, addressing ADHD treatment alongside cessation support significantly improves quit rates.

The PTSD Connection

Trauma survivors and people with PTSD have elevated smoking rates. Nicotine's anxiolytic and mood-modulating effects provide some relief from hyperarousal and emotional dysregulation — a pattern rooted in how nicotine addiction develops. The conditioned association between smoking and stress management is also particularly reinforced in PTSD (trauma often preceded smoking onset and shaped the context of its use).

PTSD presents specific cessation challenges — triggers for PTSD symptoms overlap heavily with smoking triggers. Trauma-informed cessation support is more effective than standard approaches for this population.

What Happens to Mental Health After Quitting

The consistent finding across prospective studies: people who successfully quit smoking experience significant improvements in:

Depression symptoms
Anxiety scores
Stress levels
Quality of life
Positive affect

These improvements often exceed what people achieve with antidepressant medications in some comparisons. The magnitude is surprising to many clinicians and is a strong argument against the common belief that cessation is particularly risky for people with mental health conditions.

The key qualifier: the acute withdrawal period (weeks 1–4) is genuinely difficult for people with pre-existing mental health conditions. Additional support during this period, and appropriate medication (bupropion or varenicline), reduces the risk of psychiatric exacerbation during cessation.

FAQ

Does smoking help with anxiety and depression?

Short-term: nicotine temporarily reduces withdrawal-induced anxiety and produces a brief mood lift via dopamine/serotonin release. Long-term: smoking increases baseline anxiety and depressive symptoms. Long-term quitters consistently show better mental health outcomes than long-term smokers.

Why do people with mental illness smoke more?

Multiple contributing factors: shared neurobiological vulnerability, nicotine's partial symptomatic benefit for cognitive and emotional symptoms, self-medication of medication side effects (in schizophrenia), impaired impulse control reducing cessation motivation and success, and higher rates of adversity and stress that drive nicotine use.

Is it safe to quit smoking if you have depression?

Yes, with appropriate support. Quitting can worsen depression transiently during acute withdrawal. Bupropion — which treats both depression and nicotine dependence — is the preferred pharmacological option for this population. Monitoring and support during the first 4 weeks is important.